1-2 of 2
Erica Rojas Bilbao
Close
Sort by
Journal Articles

Outcomes of First-Line Treatment (FL) of Classical Hodgkin Lymphoma (cHL) in Argentina: A Real Life Multicenter Retrospective Study

Victoria Otero, MD, Carolina Valeria Mahuad, MD PhD, Laura Korin, MD, Enriqueta Martinez, MD, Fernando Warley, MSc, MD, Hernán García Rivello, Nancy Cristaldo, MD, Dana Kohan, Marta Zerga, MD, Gonzalo Martin Garate, MD, Maria De Los Angeles Vicente Reparaz, Maria Florencia Aizpurua, MD, Erica Rojas Bilbao, Susana Cerana, Maria Eugenia Funes, Iliana Plaza, Maria Cecilia Foncuberta, MD, Anahí Vijnovich Baron, MD, Santiago Cranco, MD, Adriana Vitriu, MD, Mariela Gomez, Justina Lavalle, Claudia Casali, MD, Manuela Clavijo, Luciana Melillo, MD, Maria Cecilia Cabral Lorenzo, Augusto Miroli, MD PhD, Laura Fishman, Maximiliano J. Pavlove, MD PhD, Marcela Miodosky, Silvana Cugliari
Journal: Blood
Blood (2019) 134 (Supplement_1): 4046.
https://doi.org/10.1182/blood-2019-126314
Published: 2019
Journal Articles

Refractory and Relapse Predictive Biomarkers in Hodgkin Lymphoma and Potential Directed-Therapy Targets

Angélica María Gamboa-Cedeño, Ms, Mariángeles Castillo, Victoria Otero, MD, Natalia Paola Schutz, MD, Dorotea Beatriz Fantl, MD, Federico Jauk, MD, Hernán García Rivello, Marta Zerga, MD, Silvana Cugliari, Erica Rojas-Bilbao, MD, Myriam Nuñez, PhD, Stella Ranuncolo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2870.
https://doi.org/10.1182/blood-2018-99-115062
Published: 2018